PDF factsheet
      Z

cholesterol lowering intervention in post stroke for all type of patients, clinical trials results

atorvastatin versus placebo
SPARCL, 2006
NCT00147602
atorvastatin 80mg daily
versus
placebo
patients who had had a stroke or TIA within one to six months before study entry, had low-density lipoprotein (LDL) cholesterol levels of 2.6 to 4.9 mmol per liter, and had no known coronary heart diseasedouble blind
Follow-up duration: 4.9y (median)
simvastatin versus placebo
HPS (post troke sub group), 2004
simvastatin 40mg daily
versus
placebo
adults with cerebrovascular disease, total cholesterol >=3ยท5 mmol/L and without coronaro disease (n=1820)double blind

  Options


in first

in second

  Filter